

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neutrophil activation involved in immune response (GO:0002283) | 5.43901156 |
| 2 | glycosphingolipid catabolic process (GO:0046479) | 5.34845125 |
| 3 | oligosaccharide catabolic process (GO:0009313) | 5.33475363 |
| 4 | surfactant homeostasis (GO:0043129) | 4.97516449 |
| 5 | glycolipid catabolic process (GO:0019377) | 4.81991403 |
| 6 | amino sugar catabolic process (GO:0046348) | 4.70133810 |
| 7 | negative regulation of interleukin-12 production (GO:0032695) | 4.65031708 |
| 8 | adhesion of symbiont to host cell (GO:0044650) | 4.37250071 |
| 9 | virion attachment to host cell (GO:0019062) | 4.37250071 |
| 10 | ceramide catabolic process (GO:0046514) | 4.26354800 |
| 11 | response to lipoprotein particle (GO:0055094) | 3.97944094 |
| 12 | membrane lipid catabolic process (GO:0046466) | 3.95189618 |
| 13 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.90633008 |
| 14 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.86106062 |
| 15 | sphingolipid catabolic process (GO:0030149) | 3.84803771 |
| 16 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.83415357 |
| 17 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.82875673 |
| 18 | modulation by symbiont of host immune response (GO:0052553) | 3.82875673 |
| 19 | positive regulation by symbiont of host defense response (GO:0052509) | 3.82875673 |
| 20 | modulation by symbiont of host defense response (GO:0052031) | 3.82875673 |
| 21 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.82875673 |
| 22 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.82875673 |
| 23 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.81097832 |
| 24 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.81097832 |
| 25 | amyloid precursor protein catabolic process (GO:0042987) | 3.73660010 |
| 26 | regulation of podosome assembly (GO:0071801) | 3.73058353 |
| 27 | response to thyroid hormone (GO:0097066) | 3.72483731 |
| 28 | central nervous system myelination (GO:0022010) | 3.62745668 |
| 29 | axon ensheathment in central nervous system (GO:0032291) | 3.62745668 |
| 30 | neutrophil activation (GO:0042119) | 3.52400400 |
| 31 | keratan sulfate catabolic process (GO:0042340) | 3.51800686 |
| 32 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.50682888 |
| 33 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.50561610 |
| 34 | adhesion of symbiont to host (GO:0044406) | 3.49859116 |
| 35 | positive regulation of antigen processing and presentation (GO:0002579) | 3.49723128 |
| 36 | amyloid precursor protein metabolic process (GO:0042982) | 3.48693552 |
| 37 | granulocyte activation (GO:0036230) | 3.46316905 |
| 38 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.43719459 |
| 39 | fatty acid elongation (GO:0030497) | 3.41931791 |
| 40 | regulation of macrophage chemotaxis (GO:0010758) | 3.41302827 |
| 41 | N-acetylneuraminate metabolic process (GO:0006054) | 3.39790110 |
| 42 | respiratory burst (GO:0045730) | 3.39785977 |
| 43 | barbed-end actin filament capping (GO:0051016) | 3.37772477 |
| 44 | chemical homeostasis within a tissue (GO:0048875) | 3.37414157 |
| 45 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.32367520 |
| 46 | positive regulation of interferon-alpha production (GO:0032727) | 3.31962313 |
| 47 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.28744500 |
| 48 | regulation of antigen processing and presentation (GO:0002577) | 3.27527984 |
| 49 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.23650785 |
| 50 | positive regulation of mast cell degranulation (GO:0043306) | 3.23650785 |
| 51 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.22158067 |
| 52 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.20752633 |
| 53 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.19986408 |
| 54 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.17325015 |
| 55 | phagosome maturation (GO:0090382) | 3.14518331 |
| 56 | regulation of cholesterol storage (GO:0010885) | 3.13637042 |
| 57 | regulation of interferon-alpha production (GO:0032647) | 3.13186412 |
| 58 | T-helper 1 type immune response (GO:0042088) | 3.11839347 |
| 59 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.08450943 |
| 60 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.06830387 |
| 61 | regulation of superoxide anion generation (GO:0032928) | 3.05202640 |
| 62 | regulation of mast cell degranulation (GO:0043304) | 3.04094559 |
| 63 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.02188656 |
| 64 | regulation of chemokine biosynthetic process (GO:0045073) | 3.02019245 |
| 65 | detection of molecule of bacterial origin (GO:0032490) | 3.02004852 |
| 66 | positive regulation of mast cell activation (GO:0033005) | 3.00368980 |
| 67 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.99853586 |
| 68 | macrophage activation involved in immune response (GO:0002281) | 2.97387084 |
| 69 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.96951087 |
| 70 | positive regulation of interleukin-17 production (GO:0032740) | 2.96656688 |
| 71 | immunoglobulin mediated immune response (GO:0016064) | 2.96566216 |
| 72 | low-density lipoprotein particle clearance (GO:0034383) | 2.95447409 |
| 73 | membrane raft organization (GO:0031579) | 2.94063516 |
| 74 | regulation of mononuclear cell migration (GO:0071675) | 2.93938208 |
| 75 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.91505801 |
| 76 | peptide catabolic process (GO:0043171) | 2.88420007 |
| 77 | type I interferon signaling pathway (GO:0060337) | 2.87851262 |
| 78 | cellular response to type I interferon (GO:0071357) | 2.87851262 |
| 79 | regulation of activation of Janus kinase activity (GO:0010533) | 2.87594642 |
| 80 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.86050896 |
| 81 | response to type I interferon (GO:0034340) | 2.85684836 |
| 82 | regulation of vitamin metabolic process (GO:0030656) | 2.83708660 |
| 83 | response to peptidoglycan (GO:0032494) | 2.82178878 |
| 84 | macrophage differentiation (GO:0030225) | 2.80341033 |
| 85 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.78233533 |
| 86 | eosinophil migration (GO:0072677) | 2.78128186 |
| 87 | apoptotic cell clearance (GO:0043277) | 2.77717397 |
| 88 | cellular response to arsenic-containing substance (GO:0071243) | 2.76546118 |
| 89 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.75742585 |
| 90 | myeloid dendritic cell activation (GO:0001773) | 2.75193479 |
| 91 | positive regulation of heat generation (GO:0031652) | 2.74875950 |
| 92 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.73634165 |
| 93 | macrophage activation (GO:0042116) | 2.71372633 |
| 94 | B cell mediated immunity (GO:0019724) | 2.71137876 |
| 95 | dendritic cell differentiation (GO:0097028) | 2.71031608 |
| 96 | regulation of leukocyte degranulation (GO:0043300) | 2.70077747 |
| 97 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.69502056 |
| 98 | regulation of interleukin-17 production (GO:0032660) | 2.69176199 |
| 99 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.68985666 |
| 100 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.68317811 |
| 101 | lytic vacuole organization (GO:0080171) | 2.68276227 |
| 102 | lysosome organization (GO:0007040) | 2.68276227 |
| 103 | regulation of fever generation (GO:0031620) | 2.68149063 |
| 104 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.67450533 |
| 105 | regulation of monocyte chemotaxis (GO:0090025) | 2.67352381 |
| 106 | growth hormone receptor signaling pathway (GO:0060396) | 2.66313511 |
| 107 | detection of external biotic stimulus (GO:0098581) | 2.65505822 |
| 108 | cellular response to lipopolysaccharide (GO:0071222) | 2.63397615 |
| 109 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.63307369 |
| 110 | myeloid cell activation involved in immune response (GO:0002275) | 2.63130113 |
| 111 | detection of other organism (GO:0098543) | 2.62837326 |
| 112 | cell adhesion mediated by integrin (GO:0033627) | 2.62764477 |
| 113 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.62087930 |
| 114 | folic acid transport (GO:0015884) | 2.61333670 |
| 115 | positive regulation of interleukin-6 production (GO:0032755) | 2.59265405 |
| 116 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.59145856 |
| 117 | negative regulation of lipid storage (GO:0010888) | 2.58528145 |
| 118 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.58317634 |
| 119 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.57921049 |
| 120 | cellular response to interferon-alpha (GO:0035457) | 2.57383384 |
| 121 | regulation of T cell migration (GO:2000404) | 2.56625912 |
| 122 | response to muramyl dipeptide (GO:0032495) | 2.56382328 |
| 123 | eosinophil chemotaxis (GO:0048245) | 2.56211221 |
| 124 | leukocyte mediated cytotoxicity (GO:0001909) | 2.55781732 |
| 125 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.55262099 |
| 126 | sphingosine metabolic process (GO:0006670) | 2.54212555 |
| 127 | ensheathment of neurons (GO:0007272) | 2.53461432 |
| 128 | axon ensheathment (GO:0008366) | 2.53461432 |
| 129 | positive regulation of macrophage cytokine production (GO:0060907) | 2.52248209 |
| 130 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.51200797 |
| 131 | glycosylceramide metabolic process (GO:0006677) | 2.50255984 |
| 132 | membrane protein ectodomain proteolysis (GO:0006509) | 2.47977532 |
| 133 | myeloid cell homeostasis (GO:0002262) | 2.47954234 |
| 134 | positive regulation of interleukin-12 production (GO:0032735) | 2.47880447 |
| 135 | myelination (GO:0042552) | 2.46795853 |
| 136 | microglial cell activation (GO:0001774) | 2.46740895 |
| 137 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.46524435 |
| 138 | membrane protein proteolysis (GO:0033619) | 2.45975797 |
| 139 | positive regulation of leukocyte degranulation (GO:0043302) | 2.45336600 |
| 140 | regulation of lymphocyte migration (GO:2000401) | 2.44629717 |
| 141 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.44335954 |
| 142 | protein localization to endosome (GO:0036010) | 2.44249570 |
| 143 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.43508481 |
| 144 | monocyte chemotaxis (GO:0002548) | 2.43422345 |
| 145 | positive regulation of type 2 immune response (GO:0002830) | 2.42856298 |
| 146 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.42635701 |
| 147 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.42495453 |
| 148 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.41231216 |
| 149 | positive regulation of T cell migration (GO:2000406) | 2.40648574 |
| 150 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.40490712 |
| 151 | lung lobe morphogenesis (GO:0060463) | 2.40265407 |
| 152 | macrophage chemotaxis (GO:0048246) | 2.40135337 |
| 153 | cholesterol biosynthetic process (GO:0006695) | 2.38728672 |
| 154 | cortical actin cytoskeleton organization (GO:0030866) | 2.38263609 |
| 155 | myeloid dendritic cell differentiation (GO:0043011) | 2.38235644 |
| 156 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.37432004 |
| 157 | natural killer cell mediated immunity (GO:0002228) | 2.37432004 |
| 158 | negative regulation of interleukin-17 production (GO:0032700) | 2.36895881 |
| 159 | positive regulation of interferon-beta production (GO:0032728) | 2.36075683 |
| 160 | pinocytosis (GO:0006907) | 2.33858859 |
| 161 | NIK/NF-kappaB signaling (GO:0038061) | 2.31741592 |
| 162 | myelin maintenance (GO:0043217) | 2.30612531 |
| 163 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.30603060 |
| 164 | positive regulation of lymphocyte migration (GO:2000403) | 2.30554654 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.74009292 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.30982976 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.98583949 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.68871095 |
| 5 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.59713559 |
| 6 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.21194160 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.18096449 |
| 8 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.04088791 |
| 9 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.93676546 |
| 10 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.93196003 |
| 11 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.83361384 |
| 12 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.82993296 |
| 13 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.58451140 |
| 14 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.41987709 |
| 15 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.39542093 |
| 16 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.38869498 |
| 17 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.34813665 |
| 18 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.27339909 |
| 19 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.21920651 |
| 20 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.19217136 |
| 21 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.13516912 |
| 22 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.89441666 |
| 23 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.82052502 |
| 24 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.81195143 |
| 25 | GATA1_22025678_ChIP-Seq_K562_Human | 1.79759644 |
| 26 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.79691044 |
| 27 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.68324365 |
| 28 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.67891384 |
| 29 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.66607149 |
| 30 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.64473401 |
| 31 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.62821077 |
| 32 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.62195436 |
| 33 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.61095674 |
| 34 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.60784304 |
| 35 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.59164707 |
| 36 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.58057966 |
| 37 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.57118472 |
| 38 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.51928767 |
| 39 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49008130 |
| 40 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.48941024 |
| 41 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.48416908 |
| 42 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.47211706 |
| 43 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46144395 |
| 44 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.45379636 |
| 45 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.45170009 |
| 46 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.44657163 |
| 47 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.44506452 |
| 48 | SPI1_23127762_ChIP-Seq_K562_Human | 1.44101736 |
| 49 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.38868162 |
| 50 | MYB_26560356_Chip-Seq_TH2_Human | 1.38176295 |
| 51 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.37846434 |
| 52 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.37165461 |
| 53 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.34910646 |
| 54 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.33777950 |
| 55 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.32951673 |
| 56 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.30781218 |
| 57 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.29915077 |
| 58 | MAF_26560356_Chip-Seq_TH1_Human | 1.28366600 |
| 59 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.27251220 |
| 60 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.26303909 |
| 61 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.25695042 |
| 62 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.24034014 |
| 63 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.24034014 |
| 64 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.23289312 |
| 65 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.23172077 |
| 66 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.22966187 |
| 67 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.22649287 |
| 68 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.22303472 |
| 69 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.22052617 |
| 70 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.21579729 |
| 71 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.20768655 |
| 72 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.19386262 |
| 73 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.18790080 |
| 74 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.18142220 |
| 75 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.17726128 |
| 76 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.17368791 |
| 77 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.16588454 |
| 78 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.16537209 |
| 79 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.16383569 |
| 80 | CJUN_26792858_Chip-Seq_BT549_Human | 1.15812040 |
| 81 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.14994739 |
| 82 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.14207835 |
| 83 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.13623208 |
| 84 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.13303844 |
| 85 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.13184810 |
| 86 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.12889599 |
| 87 | * STAT1_20625510_ChIP-Seq_HELA_Human | 1.12879901 |
| 88 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.12635220 |
| 89 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.12610725 |
| 90 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.11921953 |
| 91 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.10581991 |
| 92 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.08634278 |
| 93 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.07187199 |
| 94 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06037295 |
| 95 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.05228195 |
| 96 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.05228195 |
| 97 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.04147591 |
| 98 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04131124 |
| 99 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.00355664 |
| 100 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.00083766 |
| 101 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00073177 |
| 102 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99078735 |
| 103 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.98549738 |
| 104 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.98163958 |
| 105 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.98098018 |
| 106 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.98048733 |
| 107 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97786238 |
| 108 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.96427826 |
| 109 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.96201659 |
| 110 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.94991578 |
| 111 | GATA1_19941826_ChIP-Seq_K562_Human | 0.94740382 |
| 112 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.94726292 |
| 113 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.93093755 |
| 114 | MYB_26560356_Chip-Seq_TH1_Human | 0.93043723 |
| 115 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.87853957 |
| 116 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.87836787 |
| 117 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.87681817 |
| 118 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.87008568 |
| 119 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.85443235 |
| 120 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.85275714 |
| 121 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.83900452 |
| 122 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.82906978 |
| 123 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.82511099 |
| 124 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.81804209 |
| 125 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.81501109 |
| 126 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.81438257 |
| 127 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.81262232 |
| 128 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.79668141 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 3.48949409 |
| 2 | MP0004782_abnormal_surfactant_physiolog | 3.47888516 |
| 3 | * MP0005058_abnormal_lysosome_morphology | 3.32737030 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.32310362 |
| 5 | MP0006082_CNS_inflammation | 3.11898242 |
| 6 | MP0002139_abnormal_hepatobiliary_system | 2.99910842 |
| 7 | MP0001958_emphysema | 2.99362821 |
| 8 | MP0003724_increased_susceptibility_to | 2.75222198 |
| 9 | MP0002148_abnormal_hypersensitivity_rea | 2.74490752 |
| 10 | MP0003806_abnormal_nucleotide_metabolis | 2.68969875 |
| 11 | MP0003436_decreased_susceptibility_to | 2.63682783 |
| 12 | MP0009785_altered_susceptibility_to | 2.52633833 |
| 13 | MP0002419_abnormal_innate_immunity | 2.37052986 |
| 14 | MP0000920_abnormal_myelination | 2.35505584 |
| 15 | MP0005000_abnormal_immune_tolerance | 2.29223394 |
| 16 | MP0005025_abnormal_response_to | 2.24843050 |
| 17 | MP0003191_abnormal_cellular_cholesterol | 2.24273980 |
| 18 | MP0003303_peritoneal_inflammation | 2.22459361 |
| 19 | * MP0005387_immune_system_phenotype | 2.18042488 |
| 20 | * MP0001790_abnormal_immune_system | 2.18042488 |
| 21 | MP0009840_abnormal_foam_cell | 2.17696027 |
| 22 | MP0003690_abnormal_glial_cell | 2.04176915 |
| 23 | MP0002138_abnormal_hepatobiliary_system | 1.94575531 |
| 24 | MP0001533_abnormal_skeleton_physiology | 1.92573287 |
| 25 | * MP0000685_abnormal_immune_system | 1.89569292 |
| 26 | MP0002452_abnormal_antigen_presenting | 1.85149021 |
| 27 | MP0003950_abnormal_plasma_membrane | 1.84118541 |
| 28 | MP0002295_abnormal_pulmonary_circulatio | 1.79999361 |
| 29 | MP0005671_abnormal_response_to | 1.78670405 |
| 30 | MP0002723_abnormal_immune_serum | 1.77160295 |
| 31 | MP0003448_altered_tumor_morphology | 1.76449324 |
| 32 | MP0005310_abnormal_salivary_gland | 1.67686232 |
| 33 | MP0003172_abnormal_lysosome_physiology | 1.66145911 |
| 34 | MP0002405_respiratory_system_inflammati | 1.62002969 |
| 35 | MP0000604_amyloidosis | 1.58402711 |
| 36 | MP0000343_altered_response_to | 1.57244505 |
| 37 | * MP0001819_abnormal_immune_cell | 1.54853165 |
| 38 | MP0004510_myositis | 1.53159651 |
| 39 | * MP0002420_abnormal_adaptive_immunity | 1.52017347 |
| 40 | MP0001800_abnormal_humoral_immune | 1.51967912 |
| 41 | MP0004185_abnormal_adipocyte_glucose | 1.49130352 |
| 42 | MP0001851_eye_inflammation | 1.48711116 |
| 43 | MP0004947_skin_inflammation | 1.48641000 |
| 44 | MP0001348_abnormal_lacrimal_gland | 1.47115952 |
| 45 | MP0005275_abnormal_skin_tensile | 1.37918195 |
| 46 | MP0002998_abnormal_bone_remodeling | 1.37193593 |
| 47 | MP0002254_reproductive_system_inflammat | 1.35091653 |
| 48 | MP0005164_abnormal_response_to | 1.34881746 |
| 49 | MP0009278_abnormal_bone_marrow | 1.34786572 |
| 50 | MP0001545_abnormal_hematopoietic_system | 1.32476030 |
| 51 | MP0005397_hematopoietic_system_phenotyp | 1.32476030 |
| 52 | MP0005165_increased_susceptibility_to | 1.31792803 |
| 53 | MP0001845_abnormal_inflammatory_respons | 1.27285166 |
| 54 | MP0005464_abnormal_platelet_physiology | 1.26760008 |
| 55 | MP0005388_respiratory_system_phenotype | 1.25613509 |
| 56 | MP0002133_abnormal_respiratory_system | 1.25613509 |
| 57 | MP0003566_abnormal_cell_adhesion | 1.23058672 |
| 58 | MP0003453_abnormal_keratinocyte_physiol | 1.22600963 |
| 59 | MP0002933_joint_inflammation | 1.21702550 |
| 60 | MP0002277_abnormal_respiratory_mucosa | 1.21371251 |
| 61 | MP0005083_abnormal_biliary_tract | 1.20807444 |
| 62 | MP0003075_altered_response_to | 1.19993282 |
| 63 | MP0008004_abnormal_stomach_pH | 1.19713190 |
| 64 | MP0005365_abnormal_bile_salt | 1.18688241 |
| 65 | MP0004272_abnormal_basement_membrane | 1.17858017 |
| 66 | MP0009333_abnormal_splenocyte_physiolog | 1.17493473 |
| 67 | MP0008469_abnormal_protein_level | 1.17296882 |
| 68 | MP0002090_abnormal_vision | 1.17041860 |
| 69 | MP0000383_abnormal_hair_follicle | 1.15744346 |
| 70 | MP0003300_gastrointestinal_ulcer | 1.15676976 |
| 71 | MP0003186_abnormal_redox_activity | 1.14995345 |
| 72 | MP0008260_abnormal_autophagy | 1.12567313 |
| 73 | MP0005257_abnormal_intraocular_pressure | 1.10896014 |
| 74 | MP0001346_abnormal_lacrimal_gland | 1.10623137 |
| 75 | MP0003091_abnormal_cell_migration | 1.09807374 |
| 76 | MP0010678_abnormal_skin_adnexa | 1.08536487 |
| 77 | MP0010155_abnormal_intestine_physiology | 1.07900552 |
| 78 | MP0004019_abnormal_vitamin_homeostasis | 1.07848243 |
| 79 | MP0000858_altered_metastatic_potential | 1.07482606 |
| 80 | * MP0000716_abnormal_immune_system | 1.07364309 |
| 81 | MP0002837_dystrophic_cardiac_calcinosis | 1.06098545 |
| 82 | MP0005451_abnormal_body_composition | 1.05899302 |
| 83 | MP0003828_pulmonary_edema | 1.05193441 |
| 84 | MP0001542_abnormal_bone_strength | 1.04157555 |
| 85 | MP0003634_abnormal_glial_cell | 1.01471958 |
| 86 | MP0005390_skeleton_phenotype | 0.99874693 |
| 87 | MP0009764_decreased_sensitivity_to | 0.98957989 |
| 88 | MP0005023_abnormal_wound_healing | 0.98925430 |
| 89 | MP0005408_hypopigmentation | 0.98313450 |
| 90 | MP0002166_altered_tumor_susceptibility | 0.97742322 |
| 91 | MP0003195_calcinosis | 0.93952796 |
| 92 | MP0000465_gastrointestinal_hemorrhage | 0.93932398 |
| 93 | MP0000249_abnormal_blood_vessel | 0.93662494 |
| 94 | MP0002877_abnormal_melanocyte_morpholog | 0.93350068 |
| 95 | MP0001853_heart_inflammation | 0.91249149 |
| 96 | MP0003279_aneurysm | 0.86583521 |
| 97 | MP0003329_amyloid_beta_deposits | 0.84284401 |
| 98 | MP0006054_spinal_hemorrhage | 0.84119356 |
| 99 | MP0002006_tumorigenesis | 0.83774344 |
| 100 | MP0009763_increased_sensitivity_to | 0.83247938 |
| 101 | MP0003656_abnormal_erythrocyte_physiolo | 0.81257391 |
| 102 | * MP0002429_abnormal_blood_cell | 0.79499373 |
| 103 | MP0001881_abnormal_mammary_gland | 0.78811337 |
| 104 | MP0005166_decreased_susceptibility_to | 0.75352957 |
| 105 | MP0005595_abnormal_vascular_smooth | 0.73965057 |
| 106 | MP0000733_abnormal_muscle_development | 0.73029673 |
| 107 | MP0000767_abnormal_smooth_muscle | 0.72693897 |
| 108 | MP0002398_abnormal_bone_marrow | 0.72390355 |
| 109 | MP0001243_abnormal_dermal_layer | 0.72381322 |
| 110 | MP0001663_abnormal_digestive_system | 0.72336200 |
| 111 | MP0001879_abnormal_lymphatic_vessel | 0.71856413 |
| 112 | MP0000627_abnormal_mammary_gland | 0.71580834 |
| 113 | MP0005319_abnormal_enzyme/_coenzyme | 0.71210588 |
| 114 | MP0005167_abnormal_blood-brain_barrier | 0.71084159 |
| 115 | MP0001175_abnormal_lung_morphology | 0.70772312 |
| 116 | MP0003795_abnormal_bone_structure | 0.70764131 |
| 117 | MP0004883_abnormal_blood_vessel | 0.69518050 |
| 118 | MP0005647_abnormal_sex_gland | 0.69028771 |
| 119 | MP0010386_abnormal_urinary_bladder | 0.67856753 |
| 120 | MP0001849_ear_inflammation | 0.67474931 |
| 121 | MP0003183_abnormal_peptide_metabolism | 0.67126455 |
| 122 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.64822830 |
| 123 | MP0000689_abnormal_spleen_morphology | 0.64651746 |
| 124 | MP0002332_abnormal_exercise_endurance | 0.63144779 |
| 125 | MP0000371_diluted_coat_color | 0.62455587 |
| 126 | MP0009765_abnormal_xenobiotic_induced | 0.55625895 |
| 127 | MP0000490_abnormal_crypts_of | 0.55109487 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Interstitial pulmonary disease (HP:0006530) | 6.59413714 |
| 2 | Vacuolated lymphocytes (HP:0001922) | 5.13310915 |
| 3 | Recurrent abscess formation (HP:0002722) | 5.04452572 |
| 4 | Eczematoid dermatitis (HP:0000976) | 4.84996274 |
| 5 | Increased cerebral lipofuscin (HP:0011813) | 4.73371215 |
| 6 | Recurrent bacterial skin infections (HP:0005406) | 4.63354322 |
| 7 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.42168684 |
| 8 | Mutism (HP:0002300) | 4.08501508 |
| 9 | Nuclear cataract (HP:0100018) | 4.01514165 |
| 10 | * Abnormality of macrophages (HP:0004311) | 3.93044938 |
| 11 | Dysostosis multiplex (HP:0000943) | 3.86884834 |
| 12 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.75360000 |
| 13 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.75360000 |
| 14 | Abnormality of glycolipid metabolism (HP:0010969) | 3.75360000 |
| 15 | * Loss of speech (HP:0002371) | 3.75200315 |
| 16 | Chronic otitis media (HP:0000389) | 3.72880740 |
| 17 | Axonal loss (HP:0003447) | 3.63388279 |
| 18 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.61043570 |
| 19 | Hepatosplenomegaly (HP:0001433) | 3.60427167 |
| 20 | Osteolytic defects of the hand bones (HP:0009699) | 3.57865122 |
| 21 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.57865122 |
| 22 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.56735511 |
| 23 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.35248785 |
| 24 | Complement deficiency (HP:0004431) | 3.29698643 |
| 25 | Parakeratosis (HP:0001036) | 3.28161529 |
| 26 | Systemic lupus erythematosus (HP:0002725) | 3.24178225 |
| 27 | Recurrent skin infections (HP:0001581) | 3.21020530 |
| 28 | Premature rupture of membranes (HP:0001788) | 3.01755287 |
| 29 | Agnosia (HP:0010524) | 2.91246943 |
| 30 | Autoimmune thrombocytopenia (HP:0001973) | 2.89244370 |
| 31 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.80905978 |
| 32 | Apathy (HP:0000741) | 2.80724418 |
| 33 | Diminished motivation (HP:0000745) | 2.79154052 |
| 34 | Abnormality of complement system (HP:0005339) | 2.75869448 |
| 35 | Upper motor neuron abnormality (HP:0002127) | 2.70799989 |
| 36 | Mucopolysacchariduria (HP:0008155) | 2.67320251 |
| 37 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.67320251 |
| 38 | Thick nail (HP:0001805) | 2.62304094 |
| 39 | Inappropriate behavior (HP:0000719) | 2.59685427 |
| 40 | Hematochezia (HP:0002573) | 2.55217066 |
| 41 | Spontaneous hematomas (HP:0007420) | 2.50608740 |
| 42 | Peritonitis (HP:0002586) | 2.50425728 |
| 43 | Retinal atrophy (HP:0001105) | 2.48966262 |
| 44 | Vertebral compression fractures (HP:0002953) | 2.48385780 |
| 45 | Metaphyseal irregularity (HP:0003025) | 2.48275394 |
| 46 | Pustule (HP:0200039) | 2.47968803 |
| 47 | Neuronal loss in central nervous system (HP:0002529) | 2.47724041 |
| 48 | Increased serum ferritin (HP:0003281) | 2.46726281 |
| 49 | Stomatitis (HP:0010280) | 2.44194388 |
| 50 | Obstructive lung disease (HP:0006536) | 2.43967155 |
| 51 | Chronic obstructive pulmonary disease (HP:0006510) | 2.43967155 |
| 52 | Disinhibition (HP:0000734) | 2.43381064 |
| 53 | Petechiae (HP:0000967) | 2.41635967 |
| 54 | Recurrent fungal infections (HP:0002841) | 2.41216930 |
| 55 | Tubulointerstitial fibrosis (HP:0005576) | 2.38520997 |
| 56 | Ulnar bowing (HP:0003031) | 2.38159701 |
| 57 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.35398199 |
| 58 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.35398199 |
| 59 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.35398199 |
| 60 | Abnormality of the nasal mucosa (HP:0000433) | 2.34025202 |
| 61 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.33319736 |
| 62 | Beaking of vertebral bodies (HP:0004568) | 2.33082906 |
| 63 | Respiratory distress (HP:0002098) | 2.32553941 |
| 64 | Myositis (HP:0100614) | 2.31030077 |
| 65 | Gingivitis (HP:0000230) | 2.29251227 |
| 66 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.29160858 |
| 67 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.24834945 |
| 68 | Orchitis (HP:0100796) | 2.23972078 |
| 69 | Basal ganglia calcification (HP:0002135) | 2.23450680 |
| 70 | Hypergammaglobulinemia (HP:0010702) | 2.22169247 |
| 71 | Stridor (HP:0010307) | 2.21050687 |
| 72 | Purpura (HP:0000979) | 2.20910440 |
| 73 | Premature skin wrinkling (HP:0100678) | 2.19310053 |
| 74 | Personality changes (HP:0000751) | 2.17685759 |
| 75 | Cardiomegaly (HP:0001640) | 2.17366490 |
| 76 | Nausea (HP:0002018) | 2.17038093 |
| 77 | Malnutrition (HP:0004395) | 2.15121610 |
| 78 | Mediastinal lymphadenopathy (HP:0100721) | 2.14404731 |
| 79 | Increased CSF protein (HP:0002922) | 2.13090826 |
| 80 | Nephritis (HP:0000123) | 2.13082847 |
| 81 | Asymmetric septal hypertrophy (HP:0001670) | 2.13057195 |
| 82 | Tetraparesis (HP:0002273) | 2.11892295 |
| 83 | * Dementia (HP:0000726) | 2.11611681 |
| 84 | Vasculitis (HP:0002633) | 2.11007651 |
| 85 | Conjunctival telangiectasia (HP:0000524) | 2.09948892 |
| 86 | Cellulitis (HP:0100658) | 2.08269903 |
| 87 | Osteomyelitis (HP:0002754) | 2.06762127 |
| 88 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.05828574 |
| 89 | Recurrent viral infections (HP:0004429) | 2.01633563 |
| 90 | Nasal polyposis (HP:0100582) | 2.01397032 |
| 91 | Increased IgM level (HP:0003496) | 2.01145428 |
| 92 | Poor head control (HP:0002421) | 1.99710901 |
| 93 | Progressive neurologic deterioration (HP:0002344) | 1.99613376 |
| 94 | Cerebral hemorrhage (HP:0001342) | 1.97075662 |
| 95 | Abnormality of iron homeostasis (HP:0011031) | 1.96851984 |
| 96 | Leukocytosis (HP:0001974) | 1.96365668 |
| 97 | Glomerulonephritis (HP:0000099) | 1.94612574 |
| 98 | J-shaped sella turcica (HP:0002680) | 1.94230761 |
| 99 | Polyneuropathy (HP:0001271) | 1.94126475 |
| 100 | Pulmonary infiltrates (HP:0002113) | 1.94030040 |
| 101 | Abnormality of the lumbar spine (HP:0100712) | 1.92980497 |
| 102 | Global brain atrophy (HP:0002283) | 1.90973941 |
| 103 | Abnormality of the basal ganglia (HP:0002134) | 1.90941127 |
| 104 | Xanthomatosis (HP:0000991) | 1.89030583 |
| 105 | Recurrent pneumonia (HP:0006532) | 1.88728239 |
| 106 | * Neurofibrillary tangles (HP:0002185) | 1.88222446 |
| 107 | Peripheral demyelination (HP:0011096) | 1.88183817 |
| 108 | Amyloidosis (HP:0011034) | 1.86754343 |
| 109 | Bone cyst (HP:0012062) | 1.86402305 |
| 110 | Abnormal hemoglobin (HP:0011902) | 1.85707248 |
| 111 | Spondylolisthesis (HP:0003302) | 1.85465874 |
| 112 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.84664881 |
| 113 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.84664881 |
| 114 | Renal salt wasting (HP:0000127) | 1.82068970 |
| 115 | Mucosal telangiectasiae (HP:0100579) | 1.81342653 |
| 116 | Pathologic fracture (HP:0002756) | 1.80900593 |
| 117 | Myocardial infarction (HP:0001658) | 1.80632281 |
| 118 | Retrobulbar optic neuritis (HP:0100654) | 1.79585038 |
| 119 | Optic neuritis (HP:0100653) | 1.79585038 |
| 120 | Bone pain (HP:0002653) | 1.79443737 |
| 121 | Joint stiffness (HP:0001387) | 1.78727697 |
| 122 | Sensory axonal neuropathy (HP:0003390) | 1.78702672 |
| 123 | Restrictive lung disease (HP:0002091) | 1.77744491 |
| 124 | Urticaria (HP:0001025) | 1.77354366 |
| 125 | Vascular tortuosity (HP:0004948) | 1.76285775 |
| 126 | Emphysema (HP:0002097) | 1.76226395 |
| 127 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.76165517 |
| 128 | Recurrent cutaneous fungal infections (HP:0011370) | 1.76165517 |
| 129 | Progressive visual loss (HP:0000529) | 1.74975610 |
| 130 | Abnormal umbilical cord blood vessels (HP:0011403) | 1.74841063 |
| 131 | Single umbilical artery (HP:0001195) | 1.74841063 |
| 132 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.74841063 |
| 133 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.73277946 |
| 134 | Eosinophilia (HP:0001880) | 1.73053877 |
| 135 | Arterial tortuosity (HP:0005116) | 1.73015969 |
| 136 | Thoracic kyphosis (HP:0002942) | 1.71721274 |
| 137 | Zonular cataract (HP:0010920) | 1.68282781 |
| 138 | Protuberant abdomen (HP:0001538) | 1.67707878 |
| 139 | Memory impairment (HP:0002354) | 1.60821197 |
| 140 | Premature loss of primary teeth (HP:0006323) | 1.56594757 |
| 141 | Multiple enchondromatosis (HP:0005701) | 1.54854513 |
| 142 | Hemoptysis (HP:0002105) | 1.53244144 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHB1 | 4.11129458 |
| 2 | PBK | 3.35404336 |
| 3 | STK39 | 3.17724195 |
| 4 | GRK7 | 3.11390597 |
| 5 | BLK | 2.72035105 |
| 6 | MST4 | 2.54247449 |
| 7 | TBK1 | 2.48580484 |
| 8 | TYK2 | 2.42282876 |
| 9 | MAP3K14 | 2.36085538 |
| 10 | TAOK2 | 2.33971117 |
| 11 | ACVR1B | 2.30535137 |
| 12 | IRAK4 | 2.09937850 |
| 13 | MET | 2.04104420 |
| 14 | MAP3K11 | 2.01591547 |
| 15 | PIM2 | 1.97188614 |
| 16 | LRRK2 | 1.95632569 |
| 17 | IKBKE | 1.87116324 |
| 18 | IKBKB | 1.83846836 |
| 19 | ERN1 | 1.77884911 |
| 20 | IRAK3 | 1.74277314 |
| 21 | ZAP70 | 1.66647701 |
| 22 | KIT | 1.62641958 |
| 23 | TAOK1 | 1.61376663 |
| 24 | STK10 | 1.57579979 |
| 25 | JAK3 | 1.56220857 |
| 26 | BCR | 1.52580925 |
| 27 | TGFBR2 | 1.51521278 |
| 28 | MAP2K3 | 1.49367438 |
| 29 | CSK | 1.41825843 |
| 30 | JAK1 | 1.41072370 |
| 31 | RIPK1 | 1.38988008 |
| 32 | LIMK1 | 1.38833914 |
| 33 | TESK2 | 1.38362004 |
| 34 | FGFR2 | 1.38213923 |
| 35 | MAP4K1 | 1.36518863 |
| 36 | PDK2 | 1.36274925 |
| 37 | OXSR1 | 1.35845773 |
| 38 | TRIB3 | 1.27598549 |
| 39 | FGFR4 | 1.25203908 |
| 40 | WNK4 | 1.24765365 |
| 41 | NME2 | 1.24127153 |
| 42 | EPHA3 | 1.22649030 |
| 43 | ADRBK2 | 1.20322213 |
| 44 | CDC42BPA | 1.16443050 |
| 45 | TAOK3 | 1.15400113 |
| 46 | BMX | 1.14880417 |
| 47 | MAP3K12 | 1.14025536 |
| 48 | PKN1 | 1.09658028 |
| 49 | FGR | 1.08111661 |
| 50 | ARAF | 1.07786613 |
| 51 | NEK9 | 1.07229291 |
| 52 | TESK1 | 1.05760025 |
| 53 | TGFBR1 | 1.04825186 |
| 54 | CAMKK2 | 1.03907670 |
| 55 | CSF1R | 1.03877942 |
| 56 | MAPKAPK5 | 1.00004677 |
| 57 | CLK1 | 0.96938244 |
| 58 | PAK4 | 0.94167892 |
| 59 | CHUK | 0.94165932 |
| 60 | STK16 | 0.93668263 |
| 61 | PDGFRB | 0.93438586 |
| 62 | MST1R | 0.92871525 |
| 63 | MAP3K13 | 0.92771272 |
| 64 | IRAK1 | 0.92317123 |
| 65 | ABL2 | 0.90853518 |
| 66 | MAP3K1 | 0.89651001 |
| 67 | TRPM7 | 0.86561188 |
| 68 | LCK | 0.85582329 |
| 69 | NTRK1 | 0.84406788 |
| 70 | MAP2K6 | 0.83841499 |
| 71 | RIPK4 | 0.83393555 |
| 72 | EPHA2 | 0.83355056 |
| 73 | ITK | 0.82596602 |
| 74 | STK4 | 0.82352637 |
| 75 | WNK1 | 0.81962497 |
| 76 | RPS6KA4 | 0.81880838 |
| 77 | BMPR2 | 0.80430404 |
| 78 | PRPF4B | 0.79718070 |
| 79 | PRKCQ | 0.79012536 |
| 80 | MARK3 | 0.78226861 |
| 81 | ILK | 0.76757176 |
| 82 | DDR2 | 0.76203527 |
| 83 | RPS6KA5 | 0.76107544 |
| 84 | MAP3K5 | 0.73376209 |
| 85 | HCK | 0.70857971 |
| 86 | MOS | 0.70812054 |
| 87 | CAMK1D | 0.70650954 |
| 88 | ABL1 | 0.67655851 |
| 89 | EPHB2 | 0.67614274 |
| 90 | STK24 | 0.66345320 |
| 91 | ROCK2 | 0.64835948 |
| 92 | GSK3A | 0.63051087 |
| 93 | CDK6 | 0.62931798 |
| 94 | MYLK | 0.61500214 |
| 95 | EGFR | 0.60191885 |
| 96 | JAK2 | 0.60175712 |
| 97 | STK3 | 0.60089483 |
| 98 | MAP2K2 | 0.59664022 |
| 99 | PIK3CG | 0.59495766 |
| 100 | CSNK1A1L | 0.58214132 |
| 101 | LYN | 0.57782411 |
| 102 | PTK6 | 0.57644188 |
| 103 | PRKD1 | 0.57575452 |
| 104 | IRAK2 | 0.57380985 |
| 105 | BTK | 0.56493774 |
| 106 | TEC | 0.54836370 |
| 107 | MAPKAPK2 | 0.54638728 |
| 108 | MAPK15 | 0.54109751 |
| 109 | PIM1 | 0.53753867 |
| 110 | FGFR3 | 0.53562186 |
| 111 | CSNK1G3 | 0.53333709 |
| 112 | PRKCD | 0.52813271 |
| 113 | MAP3K3 | 0.52640435 |
| 114 | SYK | 0.52276342 |
| 115 | BMPR1B | 0.51356341 |
| 116 | PRKG2 | 0.50435762 |
| 117 | TXK | 0.49601762 |
| 118 | TTN | 0.47502612 |
| 119 | NLK | 0.47014881 |
| 120 | DAPK3 | 0.46978614 |
| 121 | DAPK2 | 0.46101634 |
| 122 | ERBB4 | 0.45624889 |
| 123 | PDGFRA | 0.44942582 |
| 124 | PAK1 | 0.44526582 |
| 125 | FES | 0.44525821 |
| 126 | SIK3 | 0.43388661 |
| 127 | MATK | 0.42415334 |
| 128 | DYRK1B | 0.42176617 |
| 129 | BCKDK | 0.40004060 |
| 130 | PDPK1 | 0.39316699 |
| 131 | LATS2 | 0.32065793 |
| 132 | BRAF | 0.30734623 |
| 133 | INSR | 0.28177423 |
| 134 | RPS6KL1 | 0.25965737 |
| 135 | RPS6KC1 | 0.25965737 |
| 136 | FER | 0.25063575 |
| 137 | DYRK3 | 0.24331925 |
| 138 | MAP3K8 | 0.23876828 |
| 139 | MAPK7 | 0.23122612 |
| 140 | DAPK1 | 0.21129399 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Lysosome_Homo sapiens_hsa04142 | 3.09204651 |
| 2 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.82840664 |
| 3 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.68374187 |
| 4 | Malaria_Homo sapiens_hsa05144 | 2.34228700 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.23076308 |
| 6 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.22447661 |
| 7 | Other glycan degradation_Homo sapiens_hsa00511 | 2.20002494 |
| 8 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.08689538 |
| 9 | Pertussis_Homo sapiens_hsa05133 | 2.04918567 |
| 10 | Phagosome_Homo sapiens_hsa04145 | 2.04023672 |
| 11 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.91210295 |
| 12 | Allograft rejection_Homo sapiens_hsa05330 | 1.89431593 |
| 13 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.86990482 |
| 14 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.86521485 |
| 15 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.83686831 |
| 16 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.80667120 |
| 17 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.71498157 |
| 18 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.66619648 |
| 19 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.66007817 |
| 20 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.65196554 |
| 21 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.57186045 |
| 22 | Tuberculosis_Homo sapiens_hsa05152 | 1.55360437 |
| 23 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.50771304 |
| 24 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.50302551 |
| 25 | Measles_Homo sapiens_hsa05162 | 1.50171483 |
| 26 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.48373364 |
| 27 | Legionellosis_Homo sapiens_hsa05134 | 1.47154755 |
| 28 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.46210513 |
| 29 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.46036666 |
| 30 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.42475801 |
| 31 | Protein export_Homo sapiens_hsa03060 | 1.41061339 |
| 32 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.40637106 |
| 33 | Salmonella infection_Homo sapiens_hsa05132 | 1.33674423 |
| 34 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.31731891 |
| 35 | Shigellosis_Homo sapiens_hsa05131 | 1.29654367 |
| 36 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.29030362 |
| 37 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.26476126 |
| 38 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.26373810 |
| 39 | Asthma_Homo sapiens_hsa05310 | 1.25893167 |
| 40 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.25070616 |
| 41 | Apoptosis_Homo sapiens_hsa04210 | 1.24179490 |
| 42 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.21423728 |
| 43 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.15663174 |
| 44 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.15469668 |
| 45 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.13639470 |
| 46 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.10953844 |
| 47 | Mineral absorption_Homo sapiens_hsa04978 | 1.09077711 |
| 48 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.07111155 |
| 49 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.06493662 |
| 50 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.02956223 |
| 51 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.02891449 |
| 52 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.02196359 |
| 53 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.01941485 |
| 54 | Galactose metabolism_Homo sapiens_hsa00052 | 1.01203670 |
| 55 | Influenza A_Homo sapiens_hsa05164 | 1.00959589 |
| 56 | Hepatitis C_Homo sapiens_hsa05160 | 0.99727072 |
| 57 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.95759960 |
| 58 | Amoebiasis_Homo sapiens_hsa05146 | 0.94541140 |
| 59 | Viral myocarditis_Homo sapiens_hsa05416 | 0.92783420 |
| 60 | Proteasome_Homo sapiens_hsa03050 | 0.92765116 |
| 61 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.92058118 |
| 62 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.91436965 |
| 63 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.89613363 |
| 64 | Endocytosis_Homo sapiens_hsa04144 | 0.88077275 |
| 65 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.86262738 |
| 66 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.83040052 |
| 67 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.80396357 |
| 68 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.79898520 |
| 69 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.79777388 |
| 70 | Histidine metabolism_Homo sapiens_hsa00340 | 0.79698792 |
| 71 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.79318572 |
| 72 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.77112177 |
| 73 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.76252205 |
| 74 | Bladder cancer_Homo sapiens_hsa05219 | 0.72985724 |
| 75 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.71700183 |
| 76 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.71113497 |
| 77 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.67642486 |
| 78 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.65547201 |
| 79 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.64615966 |
| 80 | Prion diseases_Homo sapiens_hsa05020 | 0.64533447 |
| 81 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.64525322 |
| 82 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.63552390 |
| 83 | Focal adhesion_Homo sapiens_hsa04510 | 0.62269825 |
| 84 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.62150994 |
| 85 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.60876815 |
| 86 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.60536595 |
| 87 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.59860276 |
| 88 | Hepatitis B_Homo sapiens_hsa05161 | 0.58998208 |
| 89 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.58977043 |
| 90 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.57908872 |
| 91 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.57602971 |
| 92 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.57404408 |
| 93 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.55832240 |
| 94 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.55221325 |
| 95 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.52210106 |
| 96 | Platelet activation_Homo sapiens_hsa04611 | 0.51809850 |
| 97 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.51269293 |
| 98 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.47528617 |
| 99 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.45848034 |
| 100 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.44711612 |
| 101 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.44608674 |
| 102 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.44128646 |
| 103 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.43417708 |
| 104 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.42583988 |
| 105 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.42041791 |
| 106 | Tight junction_Homo sapiens_hsa04530 | 0.41018188 |
| 107 | Parkinsons disease_Homo sapiens_hsa05012 | 0.40948319 |
| 108 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.39882594 |
| 109 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.38665003 |
| 110 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.38075705 |
| 111 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.37819834 |
| 112 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.37013657 |
| 113 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.36746218 |
| 114 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.33537319 |
| 115 | Alzheimers disease_Homo sapiens_hsa05010 | 0.32466315 |
| 116 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.31024630 |
| 117 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.28016267 |
| 118 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.17729970 |
| 119 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.17424586 |
| 120 | Huntingtons disease_Homo sapiens_hsa05016 | 0.15760658 |
| 121 | HTLV-I infection_Homo sapiens_hsa05166 | 0.15349809 |
| 122 | Ribosome_Homo sapiens_hsa03010 | 0.11354292 |
| 123 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.10856183 |
| 124 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.10693798 |
| 125 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.07346184 |

